Novo Nordisk Seeks Supplier Discounts as Weight-Loss Drug Competition Intensifies
2026-07-02 08:45:02
Novo Nordisk A/S is seeking discounts from suppliers to lower its costs as it faces intensifying competition in the weight-loss drug market, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
ING’s Chris Turner Expects EUR/USD to Extend Decline Before Rebounding Later This YearNext article：
诺和诺德寻求供应商折扣降成本
